Vision and Mission
Board of Directors
Member Owned Cooperative
100% Rebate Return
WHAT WE OFFER
Remedy Pharmacy Benefits
GOVT. RELATIONS & NEWS
IPC Legislative Action Center
State Legislative Tracking
Log in to order
Forgot Login Info?
IPC Member Benefits
Rx Generics Huge Savings
Rx Brand Great Pricing
Access to 40+ Vendor Programs
OTC Profit Makers
Govt. Relations - National Updates
Read All National Updates >
Justice Department Approves CVS Acquisition of Aetna: Creates A Challenging Marketplace for All Other Health Care Providers
Oct 17, 2018
On October 10th, the U.S. Justice Department’s Antitrust Division announce its approval of the $67 billion acquisition of Aetna, the third largest U.S. health care insurer (covering 23 million lives) by CVS Health, the largest U.S. PBM, mail order and chain drug store corporation (covering 94 million pharmacy patient and 27 percent of all U.S. prescriptions). This combination operating under CVS control is promoting their value as one stop shopping for a coordinated health care option with over 1,100 Medic-clinics in CVS’ s 9800 stores nationwide. Plans have been announced since the merger approval to expand the number CVS in-store medical clinics. The only condition on the merger was for Aetna to sell its stand-alone Part D plan, which it has already announced with its sale to Wellpoint.
Rep. Doug Collins (R-Ga.) Responds to CVS Regarding PBM Issue
Jun 28, 2018
PC encourages all members to contact Rep. Doug Collins (R-GA) and thank him for his recent efforts to stand up for independent pharmacies nationwide. He recently submitted an inspiring letter to the editor which was published in the Wall Street Journal. Please contact the Congressman’s Office and convey your appreciation for his support of independent pharmacy: His office number is 202-225-9893 in Washington.
Medicare Program; Contract Year 2019 Policy and Technical Changes Final Rule
Apr 23, 2018
CMS decided to “kick the can down the road” on DIR fees at this time, but noted that the President’s Fiscal Year 2019 Budget included language that all price concessions should be at the point-of-sale. CMS believes the statute provides them with discretion to require that Part D sponsors apply at least a portion of the manufacturer rebates and all pharmacy price concessions they receive to the price of a Part D drug at the point of sale. Any new requirements regarding the application of rebates at the point of sale will be proposed through notice and comment in future rulemaking.
Govt. Relations - State Updates
Read All State Updates >
IPC Member Participation Crucial in States Renewing Cost To Dispense Surveys for Medicaid Outpatient Drug Professional Fee Calculation
Oct 17, 2018
State Medicaid programs, now in their second year of utilizing the federally mandated program to pay for Medicaid fee for service (FFS) prescription claims of an actual acquisition cost (AAC) for the drug ingredient (mostly federal NADAC pricing) and a survey-based, cost to dispense (COD) professional dispensing fee (PDF), are beginning the process this year to survey pharmacies of their Medicaid prescription dispensing costs to update their COD fee. Many states have state laws to require pharmacies to participate in these surveys which occur usually every two years.
IPC CA Members: Urge Your Senator to Support AB 315
Aug 24, 2018
We are in the final stages of the legislative process for AB 315 (Wood, Dahle, Nazarian & Stone) which would require that Pharmacy Benefit Managers (PBMs) be regulated by the California Department of Managed Health Care (DMHC). Voting will take place as early as Monday, August 27th.
Congressman Glenn Thompson Visits Crone's Drug Store
Aug 17, 2018
IPC Chairman of the Board, Chris Darling, recently had a visit from Congressman Glenn Thompson!
Legislative Action Center
State Legislative Tracking